Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges
Gunar Günther
DOI: https://doi.org/10.7861/clinmedicine.14-3-279
Clin Med June 2014 Gunar Günther
ADivision of Clinical Infectious Diseases, Medical Clinic, Research Center Borstel, Borstel, Germany, and Department of Medicine, University of Namibia School of Medicine, Windhoek, Namibia
Roles: consultant physician in respiratory medicine
Article Tools
Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges
Gunar Günther
Clinical Medicine Jun 2014, 14 (3) 279-285; DOI: 10.7861/clinmedicine.14-3-279
Citation Manager Formats
Jump to section
- Article
- ABSTRACT
- Introduction
- Recent developments in tuberculosis diagnostics and resistance testing
- Current M/XDR-TB treatment recommendations
- New drugs and innovations in M/XDR-TB therapy
- M/XDR-TB in children
- M/XDR-TB in patients co-infected with HIV
- Current shortcomings in drug-resistant TB control
- Conclusion
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China
- A 10-Year Comparative Analysis Shows that Increasing Prevalence of Rifampin-Resistant Mycobacterium tuberculosis in China Is Associated with the Transmission of Strains Harboring Compensatory Mutations
- Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens
- Role of indoleamine 2,3-dioxygenase in health and disease
- Novel drugs against tuberculosis: a clinician's perspective